20 May 2026
Renal denervation 360°: are you ready for the future?
Sponsored by Medtronic
Anchorperson:
R. Al-Lamee
Spokesperson:
F. Mahfoud
Summary
Where does renal denervation (RDN) stand today, and where is it heading next?
This EuroPCR 2026 session provides a comprehensive update on RDN, covering its safe and effective use in line with the latest European recommendations. Faculty members share practical guidance on patient selection, programme implementation, and procedural optimisation with radiofrequency RDN, drawing on more than a decade of experience with the Symplicity platform.
The discussion also looks ahead to emerging technologies and the potential role of RDN in higher-risk patient populations, highlighting future developments that could further expand its clinical impact.
Learning Objectives
- To understand the safe and effective use of renal denervation (RDN) based on latest European guidelines
- To discuss tips and tricks on the radiofrequency RDN procedure with experts in the field
- To understand how to set up your RDN programme and which patients to select
- To learn about future directions in RDN, including product developments and use in high-risk patient groups
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide001.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)